[1]
Saeidi, M. et al. 2025. Observational Study on the Safety and Efficacy of Rituximab in Multiple Sclerosis: Insights from North-Eastern Iran: Rituximab Efficacy and Safety in MS: Iran . Iranian Journal of Pharmaceutical Sciences. 21, 1 (Apr. 2025), 125–133. DOI:https://doi.org/10.22037/ijps.v21i1.45962.